Wordt geladen...

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability

SUMMARY: We evaluated the efficacy of abaloparatide in women who were at increased risk for fracture, based on CHMP recommended risk thresholds, at the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) study baseline. Among patients at high risk based on FRAX probabilities, 18 months of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arch Osteoporos
Hoofdauteurs: McCloskey, E. V., Fitzpatrick, L. A., Hu, M.-Y., Williams, G., Kanis, J. A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer London 2019
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373333/
https://ncbi.nlm.nih.gov/pubmed/30719589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11657-019-0564-7
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!